Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide in Liver Transplantation
NCT04941911Phase 2Unknown
- Sponsor
- University College London
- Start
- May 2022
- Primary completion
- Oct 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of octreotide in kidney failure (ESRD) (2 arms), sponsored by University College London. Primary endpoints: Ability to recruit patients at 180 days and Completion of the study intervention at 9.5 hours. Status: unknown.
02
Drugs
octreotide
03
Conditions
kidney failure (ESRD)
Beyond the preview
Go deeper on NCT04941911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04941911.